Conferences

On Wednesday, 10 May 2023, MDPI and the Journal of Clinical Medicine (JCM) organized the webinar on JCM entitled "The Future of COVID-19 mRNA Vaccines: Focus on Innate Immunity". The webinar highlights the future of vaccinology based on innovative approaches.

During this webinar, Dr. Nathalie Garçon first reviewed the current knowledge on adjuvants included in protein-based vaccines and their action on the innate immune system. Dr. Rein Verbeke then discussed how lipid nanoparticles and nucleoside-modified mRNA—the two major components of currently approved mRNA vaccines—contribute to the activation of the innate immune system required for the induction of protective immunity. Finally, Dr. Mihai Netea considered the activation's consequences on the immune defenses against other pathogens through the phenomenon of trained immunity.

Please note that this webinar is associated with a Special Issue in the Journal of Clinical Medicine entitled “Learning from COVID-19 Vaccines”.

Webinar Chairs and Keynote Speakers:

• Michel Goldman (Chair), Institute for Interdisciplinary Innovation in healthcare, Université libre de Bruxelles, Brussels, Belgium.
• Nathalie Garçon (Co-Chair), N3J Consulting, Belgium.
• Rein Verbeke, ¹ Ghent Research Group on Nanomedicines, Ghent University, Ghent, Belgium. ² Cancer Research Institute Ghent (CRIG), Ghent, Belgium.
• Mihai Netea, ¹ Department of Internal Medicine, Radboud Institute of Molecular Life Sciences (RIMLS) and Radboudumc Center for Infectious Diseases (RCI), Radboud University Medical Center, Nijmegen, The Netherlands. ² Department of Immunology and Metabolism, Life and Medical Sciences Institute, University of Bonn, 53115 Bonn, Germany.

https://us02web.zoom.us/webinar/register/4216811053264/WN_8mHlsSjlQFuxDBku6G8uPw